

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.
You can purchase shares of Eloxx Pharma (NASDAQ:ELOX) through any online brokerage.
Other companies in Eloxx Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Eloxx Pharma has a consensus price target of $37.50.
The stock price for Eloxx Pharma (NASDAQ: ELOX) is $12.92 last updated November 3, 2026 at 4:02 PM EST.
There are no upcoming dividends for Eloxx Pharma.
Eloxx Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Eloxx Pharma.
Eloxx Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations...